Open Access Article
Sushree Ahalya Khatua
,
Riya Ghosh
and
Amit Kumar Simlandy
*
Department of Chemical Sciences, Indian Institute of Science Education and Research Berhampur, Berhampur 760003, India. E-mail: asimlandy@iiserbpr.ac.in
First published on 22nd April 2026
Acyl transfer reactions have gained significant research attention as crucial asymmetric transformations in organic synthesis over the past few decades. Among various chiral nucleophilic catalysts, the chiral isothiourea catalysts, first introduced by Birman in 2006, have emerged as remarkably effective tools for achieving high enantioselectivity in acylation processes. Recent advances in density functional theory (DFT) calculations have elucidated the underlying mechanisms, revealing that S⋯O isothiouronium interactions between the catalyst and the acyl group, along with other non-covalent interactions, play a vital role in stabilizing the transition state. This review presents a comprehensive documentation of isothiourea-catalyzed enantioselective acylation reactions across a diverse array of alcohols and amines, outlining their methodologies, such as kinetic resolution, dynamic kinetic resolution, and atroposelective approaches. Additionally, we discuss the pertinent stereochemical models and highlight the synthetic utility of the resulting enantioenriched products, illustrating the broad applications of this catalytic strategy.
Isothiourea organocatalysts have garnered considerable attention in asymmetric catalysis due to their remarkable ability to facilitate diverse chemical transformations. Notably, the asymmetric acylation of secondary alcohols with acylating agents using the isothiourea catalyst C1 was first reported by Birman in 2006.9 This pioneering work has advanced the application of isothiourea-based catalysts in asymmetric catalysis, significantly expanding their utility. In 2008, Birman and Xi modified the non-aromatic ring of the BTM catalyst by adding substituents to synthesize HBTM (C2) and HTM catalysts, which exhibited excellent selectivity and reactivity14 (Fig. 1). Subsequently, a series of HBTM (C3) analogues was developed by researchers including Birman,15 Smith,16 Shiina,17,18 Gröger,19 and Okamoto.20 The introduction of additional substituents in these analogues altered their conformation, enhanced noncovalent interactions, and stabilized the transition state. In 2018, Smith developed a polymer-based HBTM (C4) catalyst that demonstrated excellent selectivity and exhibited recyclability.21
![]() | ||
| Fig. 1 General representation of isothiourea catalysis (pKaH in DMSO).11 | ||
These Lewis base catalysts are highly nucleophilic in nature and readily react with the acyl donor to form the acyl ammonium ion pair, where the S-atom of the catalyst interacts with the oxygen atom of the acyl functionality via n(O) → σ*(S) to control the spatial orientation of the catalyst.22,23 Common acylating agents include acyl chlorides and anhydrides. This highly electrophilic acyl intermediate readily reacts with diverse heteroatom-based nucleophiles, and the transition state leading to the product is stabilized via several non-covalent interactions. Hydrogen bonding24 of the counter anion with both the acidic proton of the nucleophile and the catalyst C–H bond, van der Waals forces, π⋯π stacking interactions, C–H/π interactions, and electrostatic interactions between the positive charge on the catalyst with the electron-rich π-system of the nucleophile allow for the precise alignment of reactants, facilitating the desired reaction pathway and helping to achieve excellent enantiocontrol.25 After releasing the product, the catalyst forms an ion pair with the acyl-donor counteranion, which undergoes base-mediated deprotonation to regenerate the catalyst for the next cycle. Among the different heteroatoms, O-acylation has been explored extensively.
In 2017, Rychnovsky and coworkers reported a methodology for the determination of the absolute configuration of β-chiral primary alcohols (1) using the competing enantioselective conversion (CEC) approach via the C2 enantioselective acylation reaction (Scheme 1). The success of this protocol largely depended on the presence of a directing group, such as a (hetero)-arene or an enone, at the stereogenic centre. The optically active alcohol was reacted in parallel with either the (R)-C2 or the (S)-C2 catalyst using propionic anhydride and iPr2NEt as the base. Generally, (S)-C2 reacts faster with heteroaryl substituents, and it depends on the substrate stereochemistry whether it is out of plane or in the plane.26 It is proposed that the π–cation interaction helps stabilize TS-1a, leading to the product.
In 2017, Tang et al. developed a chiral isothiourea-directed dynamic kinetic diastereoselective acylation (DKDA) strategy that enabled the selective synthesis of either α- or β-anomeric esters from various sugar derivatives (Scheme 2). A broad scope of acylating acid compounds, including simple and drug-derived ones, was successfully introduced, with a general preference towards the formation of β-anomeric products with the (S)-C1 catalyst. The α-anomeric esters were obtained in moderate selectivity using the (R)-C1 catalyst. The α-anomeric esters were smoothly reduced to the corresponding ethers without stereochemical scrambling. In contrast, the β-anomeric esters followed an alternative reaction pathway, leading to the formation of an acetyl ester. This methodology was further applied to the synthesis of β-glucose acyl conjugates with high selectivity that target cancer cells.27
In a separate study reported in 2017, Tang et al. developed a site-selective acylation protocol for pyranoses using an isothiourea catalyst, enabling the C-3 vs. C-2 selectivity (Scheme 3). DFT studies revealed that the observed site selectivity originates from stabilizing cation–π interactions between the C1-catalyst and the sugar substrate (5), which are influenced by the relative positions of the hydroxyl groups. These interactions depend on the substrate stereochemistry and are favored for equatorial –OH/–OR groups, which are devoid of 1,3-syndiaxial interactions. It was observed that (R)-C1 catalyst favors C3-acylation by stabilizing cation-n interactions, whereas the (S)-C2 catalyst shifts preference toward the C-2 position when the C-3 lone pair is sterically or electronically blocked. This strategy was successfully extended to disaccharides and complex sugar derivatives, including trehalose and neohesperidin dihydrochalcone (7d), demonstrating its synthetic utility for late-stage functionalization.28
In the following year, a C1-catalyzed dynamic kinetic enantioselective acylation of racemic 2-chromanol (8) was reported by the Tang group (Scheme 4). DFT studies revealed that the enantioselectivity was controlled by cation-n interactions between chromanol and catalyst (C1) in the transition state (Scheme 4). The generality of this protocol was evaluated by installing both electron-releasing and electron-deficient substituents, which led to the formation of the product (9) with excellent yield and enantioselectivity. The antipode of the product was also obtained using the (S)-C1 catalyst.29
In 2018, Smith et al. disclosed a synthetic strategy for the acylative kinetic resolution of the sterically hindered tertiary heterocyclic alcohol (10). The C3-catalyst showed high efficiency, delivering a selectivity factor of up to 200 at 1.0 mol% catalyst loading (Scheme 5). The reaction tolerated diverse aryl, alkyl, and heteroaryl substituents, affording excellent enantioselectivity. However, sterically hindered groups, such as alkyne substituents and tert-butyl substrates, showed poor enantioselectivity. DFT studies showed that (R)-TS-5a was destabilized by π⋯isothiouronium interaction. This group successfully developed a methodology for the synthesis of the 5-HT2C (10e) antagonist, yielding both enantiomers efficiently.30
In the same year, the Smith group reported the first example of acylative kinetic resolution of racemic secondary alcohols 12 using a recyclable polymer-based immobilized C4 catalyst, implemented under both batch and continuous-flow conditions (Scheme 6). A polymer-supported isothiourea catalyst was designed to achieve high enantioselectivity with excellent recyclability. For the batch reactions, an optimal catalyst loading of 1.0 mol% was identified, delivering selectivity factors of up to 600. Secondary alcohols having both electron-donating and electron-withdrawing substituents were readily accommodated, although these substrates generally exhibited lower selectivity factors. In contrast, propargylic and allylic alcohols showed good enantioselectivity. Notably, the kinetic resolution of both cis- and trans-phenylcyclohexanol was successfully achieved. The synthetic utility of this approach was highlighted through its application to the enantioselective synthesis of (S)-pronethalol (14), a β-blocker used in the treatment of cardiac arrhythmias and coronary heart disease. Furthermore, this protocol demonstrated potential for the preparation of enantiopure 1,2-amino alcohols. Continuous-flow systems demonstrated efficient catalyst recycling and scalability, underscoring the potential of this strategy for industrial applications.21
The Tang group further demonstrated that an S-adamantyl group can effectively direct the C-2 site-selective acylation of S-glycosides using an (R)-C1 catalyst (Scheme 7). This method achieved excellent selectivity (>20
:
1) across a wide variety of glycoside substrates, including diols, triols, and tetrols. In cases where the adamantyl group obstructs access to the C-2 hydroxyl group, the acylation was redirected to the C-3 position instead. DFT studies revealed that the C–H⋯π interaction between the adamantyl C–H bonds and the catalyst aromatic ring stabilized the (C-2)-transition state (TS-7a), making it more favorable. Notably, this approach enabled the conversion of selectively acylated S-glycosides into activated glycosyl donors, facilitating the efficient assembly of oligosaccharides. The synthetic utility of this strategy was illustrated by the synthesis of isoglobotrihexosylceramide, an antigen for natural killer T cells (17c).31
The axially chiral biaryl compounds are found in a wide range of bioactive molecules and pharmaceuticals, and they are also used as ligand precursors for diverse catalytic asymmetric transformations (Scheme 8). Therefore, the selective functionalization of biaryl diols, particularly through acylative kinetic resolution, has attracted sustained interest. An early example was reported by Sibi, who demonstrated the mono-acylation of biaryl diols using a fluxionally chiral DMAP-based catalyst, achieving moderate to good selectivity factors.32 In 2014, Zhao et al. reported a method for acylative kinetic resolution of an axially chiral biaryl diol using NHC catalysis.33 In 2019, Smith et al. developed a regio- and atropo-selective acylative kinetic resolution of a biaryl diol using an isothiourea catalyst (C3). During this acylative transformation, the formation of a small amount of diester product was observed along with the desired monoester (19). A control experiment shows that the presence of two hydrogen-bond donors is required to achieve both high reactivity and good selectivity. The proposed transition state features dual hydrogen-bonding interactions between the isothiourea-acyl ammonium intermediate and the diol, which enforce both the regio- and enantio-selectivity. The π–π interactions between the catalyst and the biaryl framework provide additional stabilization to TS-8a. Moreover, the NOBIN derivative (19B), where both the amine and the alcohol are present, showed excellent conversion and selectivity.34
In 2020, the Shiina group disclosed a (R)-C1-catalyzed kinetic resolution of racemic 2-hydroxyarylketones (20), yielding the product with a high enantiomeric ratio (Scheme 9). This study showed that the addition of a tertiary amine (iPr2NEt) as a base did not significantly improve selectivity (s-values). Screening of various acyl donors revealed that the sterically bulky donor produced the desired products with higher enantioselectivity. Further, 2-hydroxyarylketones bearing ortho-, meta-, and para-substituents with varying electronic properties underwent this transformation smoothly, affording the ester (21) with high s-values. The DFT calculation showed that the favorable (R)-TS-9b involves a hydrogen-bonding interaction between the hydroxyl group and pivalate, plus coordination between the ketone carbonyl and the thiouronium cation.35
In 2015, the Bressy group developed a highly enantioselective isothiourea (C3) catalyzed acylative desymmetrization of acyclic meso-1,3-diol.36 In late 2021, the Bressy group reported an enantioselective acylative kinetic resolution of α,α-difluorohydrins (rac-22), providing access to enantio-enriched organofluorine compounds (23), which are of significant relevance to the pharmaceutical and agrochemical industry (Scheme 10). The difluoromethylene group (C(sp3)F2)-containing diols showed a strong electrostatic fluorine–cation interaction, which enhanced the conversion and provided excellent enantiomeric ratios up to >99
:
1 er. This protocol was effectively applied for the double kinetic resolution of anti-4,4-difluoro-1,3-diol (22b). Mechanistic studies suggested that π–cation interactions play a key role in the initial acylation of diols, stabilizing the transition state leading to the (S)-enantiomer by 5.42 kcal mol−1 relative to the (R)-enantiomer. In contrast, replacing fluorine atoms with chlorine reduced the reactivity due to steric hindrance. One of the diols (22d) was smoothly transformed into the valuable diamine (24) in a few steps.37
Planar chiral cyclophane alcohols are valuable motifs and have been applied as chiral ligands in asymmetric catalysis and as building blocks in materials and polymer chemistry. In 2021, Waser et al. documented an acylative kinetic resolution of racemic 4-hydroxy[2,2]cyclophane (25) using the isothiourea catalyst (Scheme 11), with a selectivity factor of up to 20. The optimal C3-catalyst showed superior activity compared to the (R)-C1 catalyst. Reducing the catalyst loading decreased the selectivity while maintaining a similar conversion rate. Under the optimized conditions, various anhydrides and cyclophane alcohols were tested. Notably, isobutyric anhydride produced the best results, while acid chlorides led to racemic esters (26c).38
Molecules with chiral silicon are intriguing, but their longer Si–C bonds and vacant d-orbitals result in a labile stereocenter, making selectivity more challenging to control. Despite these challenges, in 2023, Xu et al. introduced an isothiourea-catalyzed acylative desymmetrization strategy to construct a silicon-stereogenic centre starting from an achiral organosilane (Scheme 12). This reaction scheme involved selective monoacylation of silicon-centered bisphenols (27) with 2,2-diphenylacetic pivalic anhydride. They optimized the reaction condition at a lower temperature (−40 °C) to achieve high selectivity. The substrate scope demonstrated broad functional group tolerance, including aryl groups bearing electron-donating, electron-withdrawing substituents, halogens, heteroaryl units, and varied alkyl or cycloalkyl substituents, delivering products in moderate to excellent yields and enantioselectivities. Furthermore, the methodology was successfully scaled up to gram quantities without loss of enantioselectivity and was successfully employed to synthesize phosphine oxide derivatives.39
Tertiary alcohols are notoriously difficult to resolve as steric crowding creates an obstacle in chiral recognition. In 2024, the Smith group reported a novel approach to the highly enantioselective acylative kinetic resolution of racemic pyrazolone alcohol (29) (Scheme 13). With low catalyst loading, the products were formed in excellent enantiomeric excess (ee) with selectivity greater than 200. Smith's team investigated various C-4 substituents, which showed good tolerance to alkyl, propargyl, and both electron-rich and electron-poor aromatic groups. However, the phenyl substituent at the C-5 position reduced the selectivity due to competing π–isothiouronium interactions. Bicyclic and fused systems resolved well, but benzannulated structures exhibited poor selectivity. Computational studies showed that TS-13a leading to the (S)-isomer was favored by the stabilizing NC
O–isothiouronium interaction, whereas the other transition state was less stabilized due to the alternative π–isothiouronium interaction. The late-stage acylation of several bioactive molecules, such as gemfibrozil (29e) and probenecid, was also achieved with excellent selectivity. Effective resolution has been demonstrated on a 50 g (0.22 mol) scale, showing its practicality for industrial applications.40
In the same year, Smith et al. introduced a dynamic kinetic resolution strategy for the enantioselective acylation of substituted morpholine and benzoxazine lactol (rac-31) (Scheme 14). These scaffolds are widely encountered in medicinal and agrochemical research and are present in several FDA-approved drugs, including opioid receptor ligands, antimicrobial agents, and antidepressants. This method delivered enantio-enriched products in high yields (up to 89%), with excellent enantioselectivity of up to 99
:
1 er. The C-2 substituent was generally well tolerated, although bulky or conjugated groups significantly reduced the yields of the cyclic ester. Benzoxazinone derivatives typically provided high yields, except for the C(7)-F substrate, which favored the ring-opened acylated ester in 63% yield. DFT studies indicated that ring opening and subsequent closure occurred faster than the acylation step. TS-14b gets extra stabilization arising from the N–C
O–isothiouronium interaction. Acylation of acyclic alcohol (33) was less favorable, exhibiting a higher activation barrier (15.6 kcal mol−1) than that of the cyclic ester (32) formation (13.7 kcal mol−1).41
In 2024, the Smith group established a highly enantioselective method for synthesizing tetra-substituted 3-hydroxyphthalide esters (35) via dynamic kinetic resolution using an isothiourea catalyst (Scheme 15). The use of lutidine base and a 5.0 mol% C3-catalyst loading improved the enantioselectivity. This method tolerated a broad range of substrates, including linear, branched, cyclic, and aromatic C-3 substituents, and afforded products with high enantioselectivities. Diverse anhydrides, derived from aliphatic and aryl acids, were compatible. Commercial drug-containing anhydrides, such as indomethacin and probenecid, produced the acylated products in high yields with high enantioselectivity. DFT studies suggested that the (R)-34 enantiomer reacted faster than the (S)-34 enantiomer because of stronger isothiouronium interactions of C–O within the lactol and H-bonding with the anhydride, which dominated the π–cation aryl interactions in the slow-reacting TS-15a.42
In 2024, the Li group developed a novel methodology of isothiourea-catalyzed acylative dynamic kinetic resolution of hemiaminals (rac-36) for producing N–N axially chiral pyrrolyl-oxoisoindolins (37 and 37′) together with central chirality under mild conditions (Scheme 16). This (R)-C1-catalyzed dynamic kinetic resolution protocol accommodates a broad substrate scope, including various heteroaryl- and alkyl-substituted hemiaminals, with high yields and an excellent enantioselectivity of up to 99
:
1 er. TS-16b was stabilized by the π–cation and isothiouronium interactions, whereas steric repulsion destabilized TS-16a. This approach enables the efficient synthesis of N–N axially chiral pyrrolyl oxoisoindolins, which are valuable as chiral ligands and are found in drug scaffolds.43
In 2025, Smith and his team developed an efficient methodology for the isothiourea-catalyzed acylation of the planar-chiral cyclophane alcohol (rac-38) via kinetic resolution and dynamic kinetic resolution. They found that using 5.0 mol% of the (R)-C1 catalyst with isobutyric anhydride and quinaldine base was sufficient to achieve high selectivity (up to 50%) in kinetic resolution studies (Scheme 17). In the dynamic kinetic resolution, only 2.5 mol% of the (R)-C1 catalyst and propionic anhydride yielded high selectivity. This protocol was found to be highly selective for the 12–13-membered ansa-chains, where kinetic resolution operates, and the 14–18-membered chains, where dynamic kinetic resolution operates. They rationalized the observed high selectivity by hypothesizing 1,5-chalcogen bonding between the acyl oxygen and the catalyst's sulfur atom, which locked the conformation to stabilize the transition state. The transition state acted as a checkpoint: only the enantiomer that fits the catalyst's geometry passes through the lower-energy TS-17. The other enantiomer faces steric clashes, making this pathway less favorable. The significant energy difference between transition states contributes to the observed high enantioselectivity.44
![]() | ||
| Scheme 17 Acylative kinetic resolution and DKR of planar cyclophane alcohols using isothiourea catalysts. | ||
In 2025, Li and coworkers introduced an isothiourea-catalyzed dynamic kinetic resolution strategy for the construction of enantio-enriched phthalidyl esters (41) (Scheme 18). The substrate scope proved broad and versatile; a wide range of aryl, heteroaryl, and diverse alkyl acyl chlorides were successfully converted to the corresponding products in moderate to excellent yields and enantioselectivities (up to 99
:
1 er). The DFT study revealed that cation–π interactions and steric effects favored (S)-TS-18a, while the other enantiomers faced unfavorable steric clashes. Further, the robustness of the protocol was demonstrated by performing this acylation on natural products, commercial drugs, and agrochemicals.45
In 2020, the Lu and Zhao group disclosed the synthesis of axially chiral N-sulfonyl anilides (43) by an isothiourea-catalyzed atroposelective N-acylation of sulfonamides 42 (Scheme 19). The authors thoroughly investigated various reaction parameters and found that (S)-C2 as a catalyst, cyclopentyl methyl ether as the solvent, and 4 Å MS as additives yielded the optimal result. They demonstrated a broad substrate scope, including substituted anhydrides and sulfonamides, and the products were obtained in good yields (up to 86%) and excellent enantioselectivities (up to 99.5
:
0.5 er). They have demonstrated the usefulness of the products by employing them as a catalyst (43e) for the enantioselective α-oxytosylation of propiophenone (44), and the corresponding product (45) was obtained in moderate yield and enantioselectivity.49
In 2024, Gan and Chi et al. developed an asymmetric atroposelective acylation reaction for the synthesis of N–N axially chiral indolylamides (47) with acyl chloride as an acylating agent (Scheme 20). This reaction proceeds via dynamic kinetic resolution of N-acylaminoindoles using the C3-catalyst, and the axially chiral products were obtained in excellent enantiomeric excess. N-aminoindoles with diverse substituents on the indole ring, as well as on the aryl sulfonyl ring, were obtained in excellent er. The steric repulsion between the ester group on the indole and phenyl substituents on the C3-catalyst makes the (R)-TS-20a less favorable, and the (S)-enantiomer is formed as the major product. One of the N–N axially chiral molecules shows excellent antibacterial activity against Xanthomonas axonopodis pv. citri (Xac) bacteria.50
In the same year, Zhang and Shi et al. also developed an asymmetric atroposelective acylation reaction for the synthesis of N–N axially chiral indolylamides (49) with anhydride as the acylating agent (Scheme 21). The substrate scope includes diverse substitution patterns on both the partners, and the products were formed in good to excellent yield and enantioselectivities (up to >99
:
1 er). The transition state model demonstrated that the acyl ammonium intermediate arranged the reacting groups in a precise three-dimensional configuration. TS-21a was stabilized by syn-coplanar 1,5-S⋯O interactions, allowing one atropoisomer to react smoothly while the other form was hindered. One of the synthesized compounds (49f) exhibited significant antitumor activity against the HepG2 cancer cell line.51
Nitrogenous heterocycles, such as fused pyrazoles, are valuable scaffolds commonly used in the pharmaceutical and agrochemical industries. In 2025, the Bühl and Smith group reported an enantioselective synthesis of fused pyrazolo-heterocycles (52), which was achieved via a [3 + 3] Michael addition–cyclization pathway that operates via a self-correcting amide and ester acylation mechanism (Scheme 22). Further, isothiourea C3 was not limited to serving as a catalyst; they also used isoselenourea as a catalyst to deliver products with excellent yields and enantioselectivity of up to >99
:
1 er. The DFT studies revealed that isoselenourea (C7) showed superior performance over the C3-catalyst because the acylated intermediate was stabilized by n(O) → σ*(Se–C) interaction and exhibited higher reactivity. The twisted amide geometry (10.5° Winkler–Dunitz angle) allows for reversible acylation and with a unique self-correcting pathway.52
| This journal is © The Royal Society of Chemistry 2026 |